Speaker Profile
Biography
Dr. Langelier seeks to advance the understanding and management of pneumonia, sepsis, and other infectious and inflammatory diseases through clinical investigation that harnesses multi-omic technologies. His research spans three central areas: developing novel molecular diagnostics for infectious diseases, studying the host/pathogen biology of pneumonia and sepsis, and improving methods for the surveillance of emerging infections. Among his significant contributions is the development of novel culture-independent diagnostics for pneumonia and sepsis that integrate host gene expression profiling, unbiased pathogen detection, and microbiome profiling. More recently, his lab has applied multi-omic approaches that assess both host and microbe to investigate the biology of pneumonia, sepsis and ARDS. Dr. Langelier has additionally drawn on expertise in microbial genomics to lead a genomic epidemiology service for UCSF hospitals, develop new methods for tracking antimicrobial-resistant microbes, and deploy culture-independent metagenomics for emerging pathogen surveillance.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
